Anti-Epstein-Barr Virus (EBV-p18) Antibody

The Antibodies.com goat polyclonal reagent is raised against the p18 component of the Epstein-Barr Virus (EBV) early antigen complex. This unconjugated, purified Ig fraction is supplied in a 500 µl vial and is validated for ELISA, immunofluorescence assay (IFA), and Western blot workflows in research settings studying EBV lytic-cycle reactivation.

The antibody recognizes a viral early antigen expressed during active EBV replication, making it useful for distinguishing latent from lytic infection in cell-based or tissue-based investigations. In Western blot, the reagent can resolve the early antigen band from EBV-induced cell lysates. In IFA, it can be applied to EBV-infected cells or transfected controls to visualize early-antigen expression patterns within individual cells.

Because the target is a non-structural viral protein, the antibody is intended for research use only and is not validated for diagnostic or clinical reporting. Researchers should titrate the reagent empirically for their substrate and detection system, since signal intensity depends on the proportion of cells in the lytic cycle and on the fixation or membrane conditions used.